Inventor · disambiguated record
Tetsuo Kojima
Also filed as: KOJIMA TETSUO
16 granted patents·45 pending applications·650 citations·filing 1995–2025
95Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD49HATTORI KUNIHIRO3IGAWA TOMOYUKI3KOJIMA TETSUO2ZENYTH OPERATIONS PTY LTD2
Top patents by PatentIndex Score
61 records- 0198US8562991B2Antibody molecules that bind to IL-6 receptorIGAWA TOMOYUKI·Filed 2009·Granted Oct 22, 2013·130 cites·19 claims
- 0296US10662245B2Methods of reducing IL-6 activity for disease treatmentCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted May 26, 2020·22 cites·25 claims
- 0396US9334331B2Bispecific antibodiesIGAWA TOMOYUKI·Filed 2011·Granted May 10, 2016·221 cites·33 claims
- 0495US11891457B2Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Feb 6, 2024·12 cites·14 claims
- 0595US10450381B2Methods of treatment that include the administration of bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·28 cites·84 claims
- 0693US12415835B2Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·1 cites·21 claims
- 0793US9409952B2Peptide-compound cyclization methodCHUGAI PHARMACEUTICAL CO LTD·Filed 2012·Granted Aug 9, 2016·20 cites·54 claims
- 0893US8062635B2Bispecific antibody substituting for functional proteinsHATTORI KUNIHIRO·Filed 2004·Granted Nov 22, 2011·95 cites·33 claims
- 0993US2025101118A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1092US2025382387A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1192US2025346677A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1292US2025026854A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1391US2024301075A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1490US2024190997A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1589US2024376228A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1688US8337841B2Methods of screening for antibody light chainsKOJIMA TETSUO·Filed 2004·Granted Dec 25, 2012·19 cites·22 claims
- 1788US2024010738A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1888US2023348621A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1988US2024059795A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2087US2025270345A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 2186US2023159648A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2285US8597911B2Process for producing antibodiesMIYAZAKI TARO·Filed 2004·Granted Dec 3, 2013·21 cites·14 claims
- 2385US8030461B2Methods for constructing scDb librariesCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Oct 4, 2011·14 cites·12 claims
- 2484US7732149B2Methods of screening agonistic antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2003·Granted Jun 8, 2010·27 cites·15 claims
- 2584US2023212315A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2683US2022306755A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2782US2022213217A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2881US2022267470A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2980US2022041741A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3079US2021380717A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3177US2025154285A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 3277US2021107995A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3376US5723318ADNA coding for megakaryocyte potentiatorCHUGAI SUYAKU K K·Filed 1995·Granted Mar 3, 1998·35 cites·32 claims
- 3474US2020277402A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3574US2020231688A1Antibody moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3673US2019359728A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 3773US2021206862A1Anti-il-6 receptor antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 3871US2019112390A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 3971US2025340916A1Method for synthesizing peptides in cell-free translation systemCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 4070US2018244800A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 4170US2019315884A1Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 4268US2018002443A1Antibody substituting for function of blood coagulation factor viiiCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 4366US2011245473A1Anti-IL-6 Receptor AntibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 4466US2017145111A1Antibody Substituting for Function of Blood Coagulation Factor VIIICHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 4564US2014370018A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 4664US2014037632A1Multi-specific antigen-binding molecules and uses thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 4763US2017022293A1Nucleic acid encoding bispecific antibodiesCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 4863US2019085085A1Anti-il-6 receptor antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 4963US2012253016A1Antibody molecules that bind to il-6 receptorIGAWA TOMOYUKI·Filed 2012·Application pending·0 cites
- 5062US2010003254A1Antibody Substituting for Function of Blood Coagulation Factor VIIICHUGAI PHARMACEUTICAL CO LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tetsuo Kojima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →